Home > Biocryst Pharmaceuticals Salary

Biocryst Pharmaceuticals Salary

  • 87
  • 61
  • 63
Biocryst Pharmaceuticals average salary is $90,000, median salary is $90,000 with a salary range from $90,000 to $90,000.
Biocryst Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Biocryst Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Biocryst Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Biocryst Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Biocryst Pharmaceuticals Jobs
See more Biocryst Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Biocryst Pharmaceutica... Information
  • BioCryst Pharmaceuticals, Inc
  • Industry: BioTech/Drugs
  • City: Birmingham, AL
  • BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel drugs that block key enzymes essential for cancer, cardiovascular and autoimmune diseases, and viral infections. BioCryst integrates the necessary disciplines of biology, crystallography, medicinal chemistry and computer modeling to effectively use structure-based drug design to discover and develop small molecule pharmaceuticals. Enrollment in four Phase I trials for BioCryst's lead product candidate, BCX-1777, is underway at nine U.S. cancer centers for patients with T-cell malignancies, hematologic malignancies, and other refractory cancers. BioCryst has other new enzyme targets in drug discovery including tissue factor/factor VIIa and hepatitis C polymerase.